EVALUATION BY MOLECULAR DOCKING OF INHIBITORS OF THE ENZYME PTERIDINE REDUCTASE 1 FROM LEISHMANIA

Joabe Lima Araújo, Ruan Sousa Bastos, Gardênia Taveira Santos, Jessé Lima Araújo, Jefferson Almeida Rocha

Resumo


Objective: The objective of this work is to perform a bioactive analysis of Leishmania major Pteridine Reductase 1 inhibitors (LmPTR1) through in silico molecular docking studies. Method: The receptor and the ligands were prepared using CHIMERA v. 13.1 suppressing all waste. The Lamarckian Genetic Algorithm (LGA) with global search and pseudo-Solis and Wets with local search, were the methods used in molecular docking. Each simulation consisted of 100 independent runs. The rest of the parameters were set to default values. Results: The main molecular interaction between the ligand and the receptor obtained -7.05 kcal.mol-1 of binding energy for the paromomycin, however the highest inhibition constant was obtained between the simulation of miltefosine with the receptor, obtaining 58.21 μM of inhibition constant. Conclusion: The results reveal a reduced efficacy of the four drugs tested in this


Palavras-chave


Leishmaniasis; biological activity; molecular docking

Texto completo:

PDF (English) PDF

Referências


Alvar J, Vélez I, Berna C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PloS one [Internet]. 2012; 7 (5):35671. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035671

Queiroz MJA, Alves JGB, Correia JB. Leishmaniose visceral: características clínico-epidemiológicas em crianças de área endêmica. J Pediatr [Internet]. 2004; 80 (2): 141-6. Disponível em: http://www.scielo.br/pdf/%0D/jped/v80n2/v80n2a12.pdf

Dujardin JC. Risk factors in the spread of leishmanioses: towards integrated monitoring. Trend Parasitol [Internet]. 2006; 22. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1471492205003107

Ashford RW. The Leishmaniasis as emerging and reemerging zoonoses. International Journal for Parasitology [2000]; 30: 1269-1281. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0020751900001363

Bennis I, Brouwere V, Ameur B, Laamrani AE, chichaoui S, Hamid S, et al. Control of cutaneous leishmaniasis caused by Leishmania major in Southeastern Morocco. Tropical Medicine & International Health [Internet]. 2015; 20 (10): 1297-1305. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/tmi.12543

Sundar S, Chakravarty J. Antimony toxicity. International Journal of Environmental Research and Public Health [Internet]. 2010; 7 (12): 4267–4277. Available from: https://www.mdpi.com/1660-4601/7/12/4267

Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BPD, Nakamura CV. Recent advances in leishmaniasis treatment. International Journal of Infectious Diseases [Internet]. 2011; 15 (8): 525–32. Available from: https://www.sciencedirect.com/science/article/pii/S1201971211000865

Azevedo WF, SOARES MBP. Selection of targets for drug development against protozoan parasites. Current Drug Targets [Internet]. 2009; 10 (3): 193–201. Available from: https://www.ingentaconnect.com/content/ben/cdt/2009/00000010/00000003/art00003

Kumar P, Kumar A, Verma SS, Dwivedi N, Singh N, Siddiqi MI, et al. Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies. Experimental Parasitology [Internet]. 2008; 120 (1): 73–79. Available from: https://www.sciencedirect.com/science/article/pii/S0014489408001306

Cunningham ML, Beverley SM. Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy. Molecular and Biochemical Parasitology [Internet] 113 (2): 199–213. Available from: https://www.sciencedirect.com/science/article/pii/S0166685101002134

Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem [Internet]. 2004; 25: 1605-1612. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.20084

Morris GM, Huey R, Olson AJ. Using AutoDock for ligand-receptor docking. Current protocols in bioinformatics [Internet]. 2008; 24 (1). Available from: https://currentprotocols.onlinelibrary.wiley.com/doi/abs/10.1002/0471250953.bi0814s24

Ramos RM, Perez JM, Baptista LA, Amorim HLN. Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance. Journal of molecular modeling [Internet]. 2012; 18 (9): 4013-4024. Available from: https://link.springer.com/article/10.1007/s00894-012-1383-6

Rocha JA, Rego NCS, Carvalho BTS, Silva FI, Sousa JA, Ramos RM, et al. Computational quantum chemistry, molecular docking, and ADMET predictions of imidazole alkaloids of Pilocarpus microphyllus with schistosomicidal properties. PloS one [Internet]. 2018 13 (6). Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0198476

Zhu L, Liu R, Liu T, Zou X, Xu Z, Guan H. A novel strategy to screen inhibitors of multiple aminoglycoside-modifying enzymes with ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. Journal of pharmaceutical and biomedical analysis [Internet]. 2019; 164: 520-527. Available from: https://www.sciencedirect.com/science/article/abs/pii/S073170851831611X

Chakraborty AK, Majumder HK. Mode of action of pentavalent antimonials: Specific inhibition of type I DNA topoisomerase of Leishmaniadonovani. Biochemical and biophysical research communications [Internet]. 1988; 152 (2): 605-611. Available from: https://www.sciencedirect.com/science/article/pii/S0006291X88800810

Riou G, Douc-rasy S, Kayser A. Inhibitors of trypanosome topoisomerases. 1986. Available from: http://www.biochemsoctrans.org/content/14/2/496.abstract

Ashok P, Chander S, Smith TK, Singh RP, Jha PN, Sankaranarayanan M. Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido [3, 4-b] indole derivatives as anti-leishmanial agents. Bioorganic chemistry [Internet]. 2019; 84 (98). Available from: https://www.sciencedirect.com/science/article/pii/S0045206818304942

Carnielli JBT, Crouch K, Forrester S, Silva VC, Carvalho SFG, Damasceno JD, et al. A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis. EBioMedicine [Internet]. 2018; 36. Available from: https://www.sciencedirect.com/science/article/pii/S2352396418303876

Godinho JLP, Rodrigues CS, Silva R, Urmenyi TP, Souza W, Rodrigues JCF. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice. International journal of antimicrobial agents [Internet]. 2012; 39 (4): 326-331. Available from: https://www.sciencedirect.com/science/article/pii/S092485791100464X




DOI: https://doi.org/10.26694/repis.v5i0.9056

Apontamentos

  • Não há apontamentos.


Bases/Indexadores:

Internacionais: CuidenIndex Copernicus InternationalResearch BibleLatindexCrossRefScholar Google; REDIB; PKP Index; DOAJ; MIAR; Biblioteca Virtual em Saúde (BVS); BDEnf.

Nacionais: DiadorimIBICTSumarios.orgLIVRE; periodicos CAPES.

REPIS is available in: Publons

ISSN: 2446-7901